Current Heart Failure Reports

, Volume 9, Issue 1, pp 65–74 | Cite as

Evaluating Heart Failure After Implantation of Mechanical Circulatory Support Devices

  • Keyur B. Shah
  • Daniel G. Tang
  • Richard H. Cooke
  • Michael C. Kontos
  • Neil P. Lewis
  • Gundars J. Katlaps
  • Michael L. Hess
  • Vigneshwar Kasirajan
Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)
  • 137 Downloads

Abstract

The medical community has seen an explosive rise in the utilization of implantable mechanical circulatory support devices for late-stage cardiomyopathy. Care for these complex patients requires a basic understanding of device physiology and potential complications. This review focuses on an algorithm that incorporates a careful clinical history and examination with diagnostic modalities for the evaluation of a patient who is failing therapy with a continuous-flow left ventricular assist device, as well as the general management and optimization of patients implanted with an artificial heart.

Keywords

Heart-assist devices Heart failure Heart transplantation Mechanical circulatory support Ventricular assist device Total artificial heart Nonpharmacologic therapy 

Notes

Disclosures

K. B. Shah: none; D. G. Tang: none; R. H. Cooke: none; M. C. Kontos: none; N. P. Lewis: none. Dr. Gundars J. Katlaps owns stock interest in Thoratec Corporation. M. L. Hess: none. Dr. Vigneshwar Kasirajan has served as a consultant and as a proctor for device implantation for SynCardia Systems, Inc.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • Slaughter MS, Rogers JG, Milano CA, et al. The HeartMate II investigators: advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51. This randomized controlled trial established the superiority of continuous-flow LVADS over displacement-pump LVADs.PubMedCrossRefGoogle Scholar
  2. 2.
    Miller LW, Pagani FD, Russell SD, et al. The HeartMate II clinical investigators: use of a continuous flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.PubMedCrossRefGoogle Scholar
  3. 3.
    Copeland JG, Smith RG, Arabia FA, et al. The CardioWest total artificial heart investigators: cardiac replacement with a total artificial heart as a bridge to transplantation. N Engl J Med. 2004;351:859–67.PubMedCrossRefGoogle Scholar
  4. 4.
    •• Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1–39. This is a comprehensive resource reviewing patient selection, surgical considerations, and postoperative management of patients after implantation of the HeartMate II LVAD.PubMedCrossRefGoogle Scholar
  5. 5.
    Bennett MK, Roberts CA, Dordunoo D, et al. Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2010;29:593–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Vollkron M, Voitl P, Ta J, et al. Suction events during left ventricular support and ventricular arrhythmias. J Heart Lung Transplant. 2007;26:819–25.PubMedCrossRefGoogle Scholar
  7. 7.
    Rose AG, Park SJ, Bank AJ, Miller LW. Partial aortic valve fusion induced by left ventricular assist device. Ann Thorac Surg. 2000;70:1270–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Mudd JO, Cuda JD, Halushka M, et al. Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J Heart Lung Transplant. 2008;27:1269–74.PubMedCrossRefGoogle Scholar
  9. 9.
    Cowger J, Pagani FD, Haft JW, et al. The development of aortic insufficiency in LVAD supported patients. Circ Heart Fail. 2010;3:668–74.PubMedCrossRefGoogle Scholar
  10. 10.
    Pak S, Uriel N, Takayama H, et al. Prevalence of de novo aortic insufficiency during long-term support with left ventricular assist devices. J Heart Lung Transplant. 2010;29:1172–6.Google Scholar
  11. 11.
    Myers TJ, Bolmers M, Gregoric ID, et al. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28:423–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Palardy M, Nohria A, Rivero J, et al. Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading. J Card Fail. 2010;16:218–24.PubMedCrossRefGoogle Scholar
  13. 13.
    Kormos RL, Teuteberg JJ, Pagani FD, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.PubMedCrossRefGoogle Scholar
  14. 14.
    Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Tedford RJ, Hemnes AR, Russell SD, et al. PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail. 2008;1:213–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Horton SC, Khodaverdian R, Chatelain P, et al. Left ventricular assist device malfunction: an approach to diagnosis by echocardiography. J Am Coll Cardiol. 2005;45:1435–40.PubMedCrossRefGoogle Scholar
  17. 17.
    Jaski BE, Miller DA, Hoagland PM, et al. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction. J Heart Lung Transplant. 2005;24:2060–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Raman SV, Sahu A, Merchant AZ, et al. Noninvasive assessment of left ventricular assist devices with cardiovascular computed tomography and impact on management. J Heart Lung Transplant. 2010;29:79–85.PubMedCrossRefGoogle Scholar
  19. 19.
    Boyle AJ, Russell SD, Teuteberg JJ, et al. Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J Heart Lung Transplant. 2009;28:881–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Thomas MD, Wood C, Lovett M, et al. Successful treatment of rotary pump thrombus with the glycoprotein IIb/IIIa inhibitor tirofiban. J Heart Lung Transplant. 2008;27:925–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Delgado R, Frazier OH, Myers TJ, et al. Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. J Heart Lung Transplant. 2005;24:231–3.PubMedCrossRefGoogle Scholar
  22. 22.
    Arabia FA, Copeland JG, Smith RG, et al. International experience with the CardioWest total artificial heart as a bridge to heart transplantation. Eur J Cardiothorac Surg. 1997;11(Suppl):S5–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Stribling W, Shah KB, Gunnerson K, et al. Use of nesiritide and renal function following total artificial heart implantation. J Heart Lung Transplant. 2011;30:S96.CrossRefGoogle Scholar
  24. 24.
    Delgado R, Wadia Y, Kar B, et al. Role of B-type natriuretic peptide and effect of nesiritide after total cardiac replacement with the AbioCor total artificial heart. J Heart Lung Transplant. 2005;24:1166–70.PubMedCrossRefGoogle Scholar
  25. 25.
    El-Banayosy A, Arusoglu L, Morshuis M, et al. CardioWest total artificial heart: Bad Oeynhausen experience. Ann Thorac Surg. 2005;80:548–52.PubMedCrossRefGoogle Scholar
  26. 26.
    Ensor CR, Cahoon WD, Crouch MA, et al. Antithrombotic therapy for the CardioWest temporary total artificial heart. Tex Heart Inst J. 2010;37:149–58.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Keyur B. Shah
    • 1
  • Daniel G. Tang
    • 1
  • Richard H. Cooke
    • 1
  • Michael C. Kontos
    • 1
  • Neil P. Lewis
    • 2
  • Gundars J. Katlaps
    • 1
    • 2
  • Michael L. Hess
    • 1
  • Vigneshwar Kasirajan
    • 1
  1. 1.The Advanced Heart Failure and Transplantation ProgramVirginia Commonwealth UniversityRichmondUSA
  2. 2.McGuire Veteran’s Administration HospitalRichmondUSA

Personalised recommendations